Literature DB >> 19062003

Epinephrine is associated with both erectile dysfunction and lower urinary tract symptoms.

J C Trussell1, Allen R Kunselman, Richard S Legro.   

Abstract

OBJECTIVE: To determine whether patients with erectile dysfunction (ED) have a higher incidence of insulin resistance (IR) when compared with controls.
DESIGN: Prospective case-control study.
SETTING: Academic medical center. PATIENT(S): Twenty-nine nondiabetic men aged 18-66 years were enrolled. Of these, 28 completed the study: 17 had ED, and 11 did not. INTERVENTION(S): Validated ED questionnaires, examination, serum hormones evaluation, and oral glucose tolerance testing. MAIN OUTCOME MEASURE(S): Association of IR with ED. RESULT(S): The association between worsening degrees of both lower urinary tract symptoms (LUTS) and ED was reaffirmed, as was a potential correlation between the two-epinephrine. There was a negative association between serum levels of epinephrine and scores on the 5-item version of the International Index of Erectile Dysfunction for ED (Spearman correlation coefficient = -0.38). On the other hand, men with ED were not more likely to have IR compared with controls. CONCLUSION(S): Epinephrine may be the common link between ED and LUTS. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19062003      PMCID: PMC3742327          DOI: 10.1016/j.fertnstert.2008.10.034

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  47 in total

1.  Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.

Authors:  R C Rosen; J C Cappelleri; M D Smith; J Lipsky; B M Peña
Journal:  Int J Impot Res       Date:  1999-12       Impact factor: 2.896

2.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

3.  Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism.

Authors:  J Jordan; J Tank; M Stoffels; G Franke; N J Christensen; F C Luft; M Boschmann
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

4.  Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study.

Authors:  A Martin-Morales; J J Sanchez-Cruz; I Saenz de Tejada; L Rodriguez-Vela; J F Jimenez-Cruz; R Burgos-Rodriguez
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

5.  Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes.

Authors:  J L Collins; Y Vodovotz; T Yoneyama; K Hatakeyama; A M Green; T R Billiar
Journal:  Surgery       Date:  2001-08       Impact factor: 3.982

6.  Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats.

Authors:  E Golomb; N Rosenzweig; R Eilam; A Abramovici
Journal:  J Androl       Date:  2000 Jan-Feb

7.  Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors.

Authors:  L B Sigola; R B Zinyama
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

8.  Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction? A naturalistic national cohort study.

Authors:  Peter Sun; Ralph Swindle
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

9.  Activation of sympathoadrenomedullary system increases pulmonary nitric oxide production in the rabbit.

Authors:  L C Adding; P Agvald; A Artlich; L E Gustafsson
Journal:  Eur J Pharmacol       Date:  2001-01-12       Impact factor: 4.432

Review 10.  Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links.

Authors:  Charalambos Vlachopoulos; Konstantinos Rokkas; Nikolaos Ioakeimidis; Christodoulos Stefanadis
Journal:  Eur Urol       Date:  2007-08-13       Impact factor: 20.096

View more
  1 in total

1.  Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.

Authors:  Silvia Giatti; Alessandro Di Domizio; Silvia Diviccaro; Eva Falvo; Donatella Caruso; Alessandro Contini; Roberto Cosimo Melcangi
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.